NL

Nigel Lange

Oncosil Medical Limited | Chief Executive Officer, Managing Director
Mr Lange brings with him over 30 years of experience in the medical devices industry. Since 2003, Nigel has held leadership roles with Sirtex Medical, a global leader in brachytherapy treatment for liver cancer. From 2003, Nigel served as Chief Executive Officer of Sirtex's European business, responsible for establishing their brachytherapy device in over 300 centres across Europe and the Middle East. Since 2017, Nigel served as Group Chief Commercial Officer where he was responsible for all commercial aspects of the global business. During this time, Nigel has also held interim roles including Interim Group CEO and Interim CEO of Asia Pacific. He is Member of the Risk Committee.

Company and Roles

Company
Title
Tenure
Since
OSL
Oncosil Medical Limited
  • Chief Executive Officer
  • Managing Director
4yrs, 5mthJan 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OSL
Oncosil Medical Limited
30/09/247,218,303N/A1,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OSL
Oncosil Medical Limited
19/12/23
Issued
91,500,000$0.004$366,000Issue of securities
OSL
Oncosil Medical Limited
11/05/23
Issued
1,000,000$0.010$10,000Rights issue
OSL
Oncosil Medical Limited
11/05/23
Issued
1,000,000$0.010$10,000Rights issue
OSL
Oncosil Medical Limited
25/10/22
Issued
2,469,795$0.050$123,489Issue of securities
OSL
Oncosil Medical Limited
10/06/22
Issued
500,000$0.050$25,000Rights issue